CN1097324A - Treat leukodermic medicine - Google Patents
Treat leukodermic medicine Download PDFInfo
- Publication number
- CN1097324A CN1097324A CN93115711A CN93115711A CN1097324A CN 1097324 A CN1097324 A CN 1097324A CN 93115711 A CN93115711 A CN 93115711A CN 93115711 A CN93115711 A CN 93115711A CN 1097324 A CN1097324 A CN 1097324A
- Authority
- CN
- China
- Prior art keywords
- medicine
- animal liver
- polygoni multiflori
- radix polygoni
- semen astragali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 210000004185 liver Anatomy 0.000 claims abstract description 14
- 241001465754 Metazoa Species 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 235000012054 meals Nutrition 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 206010047642 Vitiligo Diseases 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 5
- 241000287828 Gallus gallus Species 0.000 claims description 4
- 241000282894 Sus scrofa domesticus Species 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 206010025421 Macule Diseases 0.000 abstract description 7
- 238000011084 recovery Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229940027041 8-mop Drugs 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 239000009526 Fructus Akebiae Substances 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- 208000021957 Ocular injury Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical class C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The leukodermic medicine of a kind of treatment is made up of Semen Astragali Complanati, Radix Polygoni Multiflori and animal liver meal.Its manufacture method is that Semen Astragali Complanati, Radix Polygoni Multiflori are fried, and pulverizes back and animal liver meal mixing.Stain appears in the fastest 27 days white macula limits behind patient's clothes, the recovery from illness in March; White macula disappeared entirely in the slowest nearly 1 year, and without any side effects, and nearly 100 people treat and none example failure.
Description
The invention belongs to the preparation of medicine, particularly treat leukodermic Chinese medicine and compound method.
Vitiligo (Vitiligo) is a kind of dermatosis of posteriority depigmentation, but each race of the world all sieve suffers from, sickness rate is higher (according to statistics, area, Shanghai sickness rate is about 0.5%), still not exclusively clear to its cause of disease at present, thereby treatment is relatively more difficult, mostly is exploratory, and curative effect all can not be satisfied with.As belong to the Fructus Psoraleae (8-MOP of furocoumarin class, during TMEP etc.) use, for oral administration adding according to sun (deceiving) light, take the several months, but its toxic reaction is bigger, and common have (Shanghai Medical Univ's dermatological studies are compiled " clinical dermatology lecture " P285) such as indigestion and loss of appetite, anemia, leukopenia, toxic hepatitis and ocular injurys; Corticosteroid hormone uses effective sometimes, and long-term external can cause local skin atrophy (Wang Guangchao edits " skin science " 91 years second edition P195).Differentiation of tcm is then thought because of depression of liver-QI, and functional activity of QI being not smooth is fought due to the skin by ailment said due to cold or exposure again, control the plan dispersing the stagnated live-QI to relieve the stagnation of QI, QI and blood regulating, the product of assistant to dispel the wind, Radix Angelicae Sinensis commonly used, Hangzhoupro BAIYAO, RADIX CURCUMAE, Fructus Akebiae, Herba Leonuri, Fructus Atriplicis Sibiricae, Herba Xanthii grass, pearl Poria, Magnetitum etc., Chinese patent medicine has vitiligo ball etc., and its treatment phase is long, and effect is also not good.
The objective of the invention is to use the theory and practice of the traditional Chinese medical science, be mixed with a kind of Chinese medicine preparation, vitiligo is had specially good effect, and without any side effects.
The main cause that skin color changes is the melanocyte dysbolismus, and the formation of melanocyte is relevant with the biochemical process of tyrosine activity, ultraviolet and copper, zinc ion.The intake of one aspect of the present invention increase patient's tyrosine, copper, zinc ion is taked kidney invigorating and YANG supporting, on the other hand with raise immunity.For reaching this purpose, the present invention uses Chinese medicine Semen Astragali Complanati, Radix Polygoni Multiflori and animal liver meal to prepare, Semen Astragali Complanati, bitter in the mouth, warm in nature, nontoxic; Radix Polygoni Multiflori is nontoxic, and the two all has the kidney invigorating, Yang strengthening function; Contain a large amount of tyrosine and zinc ion in the animal livers.Modern medicine studies show that Semen Astragali Complanati has immunologic function.Consisting of of every pair of medicine of the present invention:
Semen Astragali Complanati 30～50g
Radix Polygoni Multiflori 20～40g
Animal liver meal 40～60g
Its method for making is: Semen Astragali Complanati, clean, the dry back of Radix Polygoni Multiflori fried with slow fire, pulverizes, sieves, make it all by 60 mesh sieves, with the animal liver meal mix homogeneously.Animal liver meal is the dry powder of Hepar Sus domestica or Hepar Gallus domesticus preferably, and method for making is that the fresh animal liver is cleaned, and boils or cook, cold drying, pulverizing form.1 pair of the every clothes of patient, day clothes three times, boiled water is taken after mixing it with water.
Nearly hundred patients with vitiligo are treated with medicine of the present invention, year, order was between 14～45 years old, ill is not wait in 2～11 years, great majority used different in, western drug treated, effect is all unsatisfactory, take medicine of the present invention after, stain appears in 27 days the fastest white macula edges, recovery from illness in three months, white macula disappears in the slowest 1 year, none example failure.
The present invention has broken through diagnosis theory and the Therapeutic Method of the traditional Chinese medical science to leucoderma hearsay system, change dispersing liver and promoting blood circulation and dispel the wind and be to have used the Chinese medicine Semen Astragali Complanati first by kidney invigorating and YANG supporting, be equipped with Radix Polygoni Multiflori, animal liver meal is made oral medicine, can impel melanocyte to form after the patient takes, reach the ideal effect of treatment.
Example 1
Treatment vitiligo pharmaceutical formulation is:
Semen Astragali Complanati 5.4kg
Radix Polygoni Multiflori 3.6kg
Hepar Gallus domesticus powder 7.2kg
With Semen Astragali Complanati, Radix Polygoni Multiflori clean, dry, fry, pulverize, sieve, with Hepar Gallus domesticus powder mixing, be divided into 180 parts (paying), be the dose in February.
Certain woman, 14 years old, found before 4 years that white macula appears in abdominal part, growing up gradually is strip, has nowadays developed nearly 20 centimeter length, 10 centimetres of wide areas.Once many places seek medical advice invalid.Use medicine of the present invention, day clothes 3 times, each 1 pair, 2 bluish white macular areas dwindle, and obey the February white macula again and all disappear.
Example 2
Pharmaceutical formulation is:
Semen Astragali Complanati 13.5kg
Radix Polygoni Multiflori 10.5kg
Hepar Sus domestica powder 16.2kg
Medicine method for making such as example 1 are 270 pairs, March dosing.
Certain man, 50 years old, suffer from vitiligo for many years, two the back of the hand and last arm bulk, fritter white fleck place, being linked to be of having is large stretch of.Once repeatedly with patent medicine, folk prescription treatment, all there was not produce effects.Taking three months white maculas of this medicine all disappears.
Claims (3)
1, a kind ofly treat consisting of of the medicine of leucoderma disease, its every pair medicine:
Semen Astragali Complanati 30～50g
Radix Polygoni Multiflori 20～40g
Animal liver meal 40～60g
2, medicine as claimed in claim 1 is characterized by the dry powder that described animal liver meal is Hepar Sus domestica or Hepar Gallus domesticus; Its method for making is boiled or is cooked for the fresh animal liver that will clean, forms through cold drying, pulverizing.
3, the method for making of treatment vitiligo medicine is characterized by Semen Astragali Complanati, Radix Polygoni Multiflori are fried with slow fire, pulverizes, sieves and the animal liver meal mixing forms.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93115711A CN1040621C (en) | 1993-07-29 | 1993-07-29 | Medicine for treating leucoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93115711A CN1040621C (en) | 1993-07-29 | 1993-07-29 | Medicine for treating leucoderma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1097324A true CN1097324A (en) | 1995-01-18 |
| CN1040621C CN1040621C (en) | 1998-11-11 |
Family
ID=4991253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93115711A Expired - Fee Related CN1040621C (en) | 1993-07-29 | 1993-07-29 | Medicine for treating leucoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1040621C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060379C (en) * | 1997-09-02 | 2001-01-10 | 史培明 | Chines medicine for treating vitiligo and preparation method thereof |
| CN105030995A (en) * | 2014-05-09 | 2015-11-11 | 蒋盘君 | Traditional Chinese medicine powder for treating vitiligo |
-
1993
- 1993-07-29 CN CN93115711A patent/CN1040621C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060379C (en) * | 1997-09-02 | 2001-01-10 | 史培明 | Chines medicine for treating vitiligo and preparation method thereof |
| CN105030995A (en) * | 2014-05-09 | 2015-11-11 | 蒋盘君 | Traditional Chinese medicine powder for treating vitiligo |
| CN105030996A (en) * | 2014-05-09 | 2015-11-11 | 蒋盘君 | Granules for treating vitiligo |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1040621C (en) | 1998-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101041041A (en) | Chinese traditional medicine compound took orally for treating vitligo | |
| CN101439114B (en) | Chinese medicine for treating burn and scald, and preparation method thereof | |
| CN108619473A (en) | A kind of Chinese medicine fuming-lotion for treating diabete peripheral herve pathology | |
| CN101073575A (en) | Capsule for treating acne | |
| CN1040621C (en) | Medicine for treating leucoderma | |
| CN102805806B (en) | Medicine for treating acne, maintaining beauty and keeping young, and preparation method thereof | |
| CN105456428A (en) | Traditional Chinese medicine formula for inhibiting regrowth of tumor cells and preparation method thereof | |
| CN102743539B (en) | Traditional Chinese medicine for treating coronary heart disease with warming yang and promoting blood circulation effects, and preparation method for same | |
| CN104800389A (en) | External use liquid medicine for treating eczema | |
| CN109078081A (en) | A kind of intelligence system emplastrum and preparation method thereof for treating various acne | |
| CN101057922A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN1169535C (en) | Chinese medicine for treating hepatitis B | |
| CN1059327C (en) | Inflammation diminishing and asthma stopping cream | |
| CN100350934C (en) | Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof | |
| CN1140289C (en) | Gynopathy treating Chinese medicine with functions of diminishing inflammation and eliminating spot and its prepn | |
| CN105641352A (en) | Medicinal preparation for treating facial stain and application thereof | |
| CN1145229A (en) | A manufacturing method of cleansing powder for human viscera | |
| CN1052640C (en) | Pills replenishing bone marrow | |
| CN1141124C (en) | Chinese medicine preparation for treating leukoderma and its preparation | |
| CN112057555B (en) | A composition for treating keratotic skin diseases and its preparation method | |
| CN1179952A (en) | Formula composition of kebixiao pill and kebixiao plaster and its producing method | |
| CN106822300A (en) | A kind of Chinese medicine preparation of anti-acne U.S. face | |
| CN1244412A (en) | Menstruation regulating and face nourishing pill | |
| CN105194526A (en) | Traditional Chinese medicine for treating hepatic calculi | |
| CN1050759C (en) | Medicinal composite for hysteromyoma and preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Address after: Department of Dermatology, Wafangdian first people's Hospital Applicant after: Wu Xinhua Inventor after: Wu Xinhua Address before: Wafangdian City grain worker school Applicant before: Hao Lianjia Inventor before: Hao Lianjia |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HAO LIANJIA TO: WU XINHUA; APPLICANT; FROM: HAO LIANJIA TO: WU XINHUA |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |